Interpace Biosciences, Inc. (IDXG)
2.20
0.00 (0.00%)
USD |
OTCM |
Apr 16, 15:20
Interpace Biosciences Market Cap : 60.94M for April 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| FONAR Corp. | 118.20M |
| Thermo Fisher Scientific, Inc. | 191.66B |
| XWELL, Inc. | 8.244M |
| Hypha Labs, Inc. | 3.657M |
| Veracyte, Inc. | 2.623B |
Market Cap Related Metrics
| PE Ratio | 2.874 |
| PS Ratio | 1.243 |
| Price to Book Value | 2.725 |
| Price to Free Cash Flow | 8.793 |
| Price | 2.20 |
| Earnings Yield | 34.79% |
| Operating PE Ratio | 11.79 |
| Normalized PE Ratio | 2.890 |